The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-isopropyl-3-(5-(4-((2,2,2-trifluoroethylamino)methyl)phenyl)-1H-pyrazol-3-yl)benzamide ID: ALA1683434
PubChem CID: 53324197
Max Phase: Preclinical
Molecular Formula: C22H23F3N4O
Molecular Weight: 416.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)NC(=O)c1cccc(-c2cc(-c3ccc(CNCC(F)(F)F)cc3)[nH]n2)c1
Standard InChI: InChI=1S/C22H23F3N4O/c1-14(2)27-21(30)18-5-3-4-17(10-18)20-11-19(28-29-20)16-8-6-15(7-9-16)12-26-13-22(23,24)25/h3-11,14,26H,12-13H2,1-2H3,(H,27,30)(H,28,29)
Standard InChI Key: XNUGQQDGTQJPAK-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 32 0 0 0 0 0 0 0 0999 V2000
3.7226 -17.3771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7135 -18.1991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4231 -18.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1427 -18.2126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1479 -17.3874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4376 -16.9719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8681 -16.9839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6545 -17.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1467 -16.5865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6613 -15.9184 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8797 -16.1645 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9692 -16.6296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3463 -17.3693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1723 -17.4124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6215 -16.7166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2431 -15.9801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4182 -15.9406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6971 -15.2787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5240 -15.3186 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3164 -14.5503 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9064 -16.0497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9956 -18.6035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2866 -18.1841 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5688 -18.5884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4651 -16.7452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7297 -16.0839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8597 -18.1688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1420 -18.5731 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.8684 -17.3451 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.1402 -17.7504 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5 7 1 0
14 15 2 0
7 8 2 0
15 16 1 0
3 4 2 0
16 17 2 0
17 12 1 0
16 18 1 0
4 5 1 0
18 19 1 0
2 3 1 0
18 20 2 0
8 9 1 0
19 21 1 0
9 10 2 0
2 22 1 0
10 11 1 0
22 23 1 0
11 7 1 0
23 24 1 0
5 6 2 0
21 25 1 0
9 12 1 0
21 26 1 0
6 1 1 0
24 27 1 0
12 13 2 0
27 28 1 0
1 2 2 0
27 29 1 0
13 14 1 0
27 30 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 416.45Molecular Weight (Monoisotopic): 416.1824AlogP: 4.53#Rotatable Bonds: 7Polar Surface Area: 69.81Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.43CX Basic pKa: 4.43CX LogP: 4.24CX LogD: 4.24Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.53Np Likeness Score: -1.77
References 1. Gamber GG, Meredith E, Zhu Q, Yan W, Rao C, Capparelli M, Burgis R, Enyedy I, Zhang JH, Soldermann N, Beattie K, Rozhitskaya O, Koch KA, Pagratis N, Hosagrahara V, Vega RB, McKinsey TA, Monovich L.. (2011) 3,5-diarylazoles as novel and selective inhibitors of protein kinase D., 21 (5): [PMID:21300545 ] [10.1016/j.bmcl.2011.01.014 ]